Curis Inc Earnings

The next earnings date for Curis Inc has not yet been scheduled.

Analyst Estimates of Curis Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Curis Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/05/2025---$-0.6855.12%
05/05/2025Before Market$-1.250.75%
11/01/2024Before Market$-1.707.61%
08/01/2024Before Market$-2.03-21.56%
05/07/2024Before Market$-2.053.30%
02/08/2024Before Market$-2.033.79%
11/02/2023Before Market$-2.138.58%
08/03/2023After Market$-0.120.00%
05/04/2023After Market$-0.12-20.00%
03/13/2023Before Market$-0.127.69%
11/09/2022After Market$-0.1417.65%
08/04/2022After Market$-0.170.00%
05/05/2022After Market$-0.18-12.50%
02/24/2022After Market$-0.15-15.38%
11/09/2021After Market$-0.127.69%
08/03/2021After Market$-0.12-9.09%
05/12/2021After Market$-0.11-22.22%
03/16/2021After Market$-0.11-22.22%
11/10/2020After Market$-0.1115.38%
08/04/2020After Market$-0.1710.53%
06/24/2020After Market$-0.28---
03/19/2020---$-5.20-2,500.00%
11/05/2019---$-3.80-1,800.00%
08/06/2019---$-4.40-2,215.79%
05/14/2019---$-6-3,057.89%
03/26/2019After Market$-0.1814.29%
11/01/2018Before Market$-0.2224.14%
08/02/2018Before Market$-0.2633.33%
05/03/2018Before Market$-0.3323.26%
03/08/2018Before Market$-0.2544.44%
11/07/2017Before Market$-0.55-17.02%
08/03/2017Before Market$-0.50-6.38%
05/04/2017Before Market$-0.55-27.91%
03/09/2017Before Market$-0.4018.37%
11/03/2016Before Market$-1.05-114.29%
08/04/2016Before Market$-0.452.17%
05/09/2016Before Market$-0.3510.26%
02/29/2016Before Market$-0.5018.03%
11/09/2015Before Market$-0.2051.22%
08/06/2015Before Market$-0.303.23%
05/07/2015Before Market$-0.35-16.67%
02/24/2015After Market$-0.35-2.94%
11/10/2014Before Market$-0.30-36.36%
08/07/2014---$-0.1061.54%
05/08/2014---$-0.303.23%
02/20/2014---$-0.2534.21%
11/06/2013---$-0.10-66.67%
08/05/2013---$-0.1054.55%
04/30/2013---$-0.30-30.43%
02/20/2013---$-0.2050.00%
11/06/2012---$-0.2051.22%
08/02/2012---$-0.2025.93%
05/08/2012---$0.157.14%
02/08/2012---$0.3525.00%
10/27/2011---$-0.2510.71%
07/28/2011---$-0.3014.29%
04/28/2011---$-0.45-32.35%
02/10/2011---$-0.35-12.90%
10/28/2010---$-0.1041.18%
08/03/2010---$-0.1525.00%
05/06/2010---$0.3030.43%
02/25/2010---$-0.2013.04%
10/29/2009---$-0.303.23%
07/30/2009---$-0.35-6.06%
05/05/2009---$0.10600.00%
02/10/2009---$-0.1511.76%
10/28/2008---$-0.35-9.38%
07/30/2008---$-0.1540.00%
04/30/2008---$-5.42---
02/14/2008---$6.79---
10/30/2007---$-6.46---
07/31/2007---$-0.40-14.29%
05/02/2007---$-7.17---
02/14/2007---$1.38---
11/09/2006---$-0.1557.14%
07/27/2006---$-0.40-14.29%
05/09/2006---$-8.29---
02/14/2006---$-0.1078.26%
11/14/2005---$-0.4018.37%
08/09/2005---$-0.50-16.28%
04/26/2005---$-0.5515.38%
02/15/2005---$-0.2052.38%
10/26/2004---$-0.4513.46%
07/20/2004---$-0.509.09%
04/28/2004---$-0.509.09%
02/05/2004---$-0.85-70.00%
11/03/2003---$10.82---
07/30/2003---$-0.75-650.00%
03/31/2003---$-14.09---
12/31/2002---$33.98---
09/30/2002---$-18.21---
06/30/2002---$-220.11---
03/31/2002---$-55.68---
12/31/2001---$-50.89---
11/14/2001---$-4.45-45.90%
08/10/2001---$-3.05-187.14%
05/09/2001---$-2.65-175.71%
12/31/2000---$-71.40---
09/30/2000---$-1,519.37---

More About Curis Inc

Website
https://www.curis.com
Country
USA
Full Time Employees
20

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small-molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreements with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed three programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

“Curis Inc Earnings” Can Refer to the Curis Inc Earnings Date

Some people say “Curis Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Curis Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Curis Inc Stock on the Earnings Date

If you own Curis Inc stock (CRIS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Curis Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Curis Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Curis Inc Earnings

You can contact us any time if you would like to ask questions about Curis Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.